Search

Search Constraints

You searched for: Author/Creator van Lanschot, Jan

Search Results

1. 10-year outcome of a randomized trial comparing neoadjuvant chemoradiotherapy and surgery with surgery alone for esophageal cancer (CROSS trial). Issue 2 (February 2021)

2. 266. EXTENSION OF FDG-PET-BASED RADIOMIC MODELS ON IDENTIFICATION OF PATIENTS WITH RESIDUAL ESOPHAGEAL CANCER AFTER NEOADJUVANT CHEMORADIOTHERAPY. (24th September 2022)

3. 508. OUTCOME OF NEOADJUVANT CHEMORADIOTHERAPY PLUS SURGERY FOR ESOPHAGEAL SQUAMOUS CELL CARCINOMA IN EAST ASIA VERSUS WESTERN EUROPE. (24th September 2022)

5. Outcome of neoadjuvant chemoradiotherapy plus surgery for esophageal squamous cell carcinoma in East Asia versus Western Europe. Issue 2 (February 2022)

6. Patient preferences for active surveillance versus standard surgery after neoadjuvant chemoradiotherapy in esophageal cancer treatment. Issue 2 (February 2022)

7. The need for information and support in decision-making for patients with esophageal cancer who prefer standard surgery or active surveillance. Issue 2 (February 2023)